Cysview
Optical imaging, Bladder cancer, Carcinoma in situ, Cystoscopy, Hexvix
Herausgegeben: Naoum, Jordan
Versandkostenfrei!
Versandfertig in 6-10 Tagen
19,99 €
inkl. MwSt.
PAYBACK Punkte
10 °P sammeln!
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Cysview is an optical imaging agent designed to enhance detection of bladder cancer, in particular carcinoma in situ (CIS), it reveals lesions that may not be seen with standard white light cystoscopy. Cysview is marketed in Europe as Hexvix. Cysview is licensed by GE Healthcare from Photocure ASA a Norwegian pharmaceutical company that develops and sells pharmaceuticals and medical devices for the photodynamic treatment and diagnosis of cancer and selected dermatolog...
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Cysview is an optical imaging agent designed to enhance detection of bladder cancer, in particular carcinoma in situ (CIS), it reveals lesions that may not be seen with standard white light cystoscopy. Cysview is marketed in Europe as Hexvix. Cysview is licensed by GE Healthcare from Photocure ASA a Norwegian pharmaceutical company that develops and sells pharmaceuticals and medical devices for the photodynamic treatment and diagnosis of cancer and selected dermatology indications.
Andere Kunden interessierten sich für
